Jyong Biotech (NASDAQ: MENS) CFO ZHANG WEI files initial Form 3

Rhea-AI Filing Summary

Jyong Biotech Ltd. CFO files initial ownership report. CFO ZHANG WEI (VIVI) filed a Form 3 as an officer of Jyong Biotech Ltd. (ticker MENS). The filing lists her as Chief Financial Officer and does not report any share purchases, sales, or other transactions.

Key Terms

Form 3, beneficial ownership, reporting person

3 terms

Form 3 regulatory

"filed a Form 3 as an officer of Jyong Biotech Ltd."

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

beneficial ownership financial

"initial statement of beneficial ownership as a company insider"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

reporting person regulatory

"The reporting person is ZHANG WEI (VIVI), identified as the Chief Financial Officer"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

ZHANG WEI (VIVI)

(Last) (First) (Middle)

23F-3, NO. 95, SEC. 1, XINTAI 5TH RD

(Street)

NEW TAIPEI CITY TAIWAN, PROVINCE OF CHINA 221

(City) (State) (Zip)

TAIWAN

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
04/13/2026

3. Issuer Name and Ticker or Trading Symbol
Jyong Biotech Ltd. [ MENS ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	WEI (VIVI) ZHANG	04/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Jyong Biotech (MENS) Form 3 filing report?

The Form 3 reports that ZHANG WEI (VIVI) is a Chief Financial Officer of Jyong Biotech Ltd. It serves as her initial statement of beneficial ownership as a company insider, without listing any specific share purchases, sales, or derivative positions.

Does the MENS Form 3 show any insider buying or selling?

No, this Form 3 does not show insider buying or selling. It contains no reported transactions or derivative exercises and functions only as an initial ownership statement for the CFO, indicating her status as an officer of Jyong Biotech Ltd.

Who is the reporting person in the Jyong Biotech (MENS) Form 3?

The reporting person is ZHANG WEI (VIVI), identified as the Chief Financial Officer of Jyong Biotech Ltd. Form 3 designates her as an officer and falls under insider reporting rules due to her executive role with the company.

Why is Jyong Biotech’s CFO required to file a Form 3?

As Chief Financial Officer, ZHANG WEI (VIVI) is considered an insider under securities rules and must file Form 3. This filing establishes her initial beneficial ownership status when she becomes subject to ongoing insider reporting obligations for Jyong Biotech Ltd.